News Daily News Acute HF Patients Live Longer When Seen by Specialists Michael O'Riordan August 09, 2024
News Conference News ACC 2024 Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It Michael O'Riordan March 27, 2024
News Conference News ESC 2023 ESC Focused Update on HF Synthesizes New Trial Data for Practical Use L.A. McKeown September 01, 2023
News Daily News US and European Valvular Guidelines Mostly Concordant, Analysis Finds L.A. McKeown August 21, 2023
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Features Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle Shelley Wood October 08, 2021
News Daily News ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study Michael O'Riordan July 27, 2021
News Daily News Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms Michael O'Riordan April 02, 2021
News Conference News ESC 2020 COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020 Michael O'Riordan September 04, 2020
News Daily News New European Hypertension Guidelines Not in Harmony With US Guidance Todd Neale June 11, 2018